GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.

Have any questions? Please email us at ecoliwiki@gmail.com

TableEdit

Jump to: navigation, search

PMID:19861679

You don't have sufficient rights on this wiki to edit tables. Perhaps you need to log in. Changes you make in the Table editor will not be saved back to the wiki

See Help for Help on this wiki. See the documentation for how to use the table editor

Citation

Fisher, CL, Pineault, N, Brookes, C, Helgason, CD, Ohta, H, Bodner, C, Hess, JL, Humphries, RK and Brock, HW (2010) Loss-of-function Additional sex combs like 1 mutations disrupt hematopoiesis but do not cause severe myelodysplasia or leukemia. Blood 115:38-46

Abstract

The Additional sex combs like 1 (Asxl1) gene is 1 of 3 mammalian homologs of the Additional sex combs (Asx) gene of Drosophila. Asx is unusual because it is required to maintain both activation and silencing of Hox genes in flies and mice. Asxl proteins are characterized by an amino terminal homology domain, by interaction domains for nuclear receptors, and by a C-terminal plant homeodomain protein-protein interaction domain. A recent study of patients with myelodysplastic syndrome (MDS) and chronic myelomonocytic leukemia (CMML) revealed a high incidence of truncation mutations that would delete the PHD domain of ASXL1. Here, we show that Asxl1 is expressed in all hematopoietic cell fractions analyzed. Asxl1 knockout mice exhibit defects in frequency of differentiation of lymphoid and myeloid progenitors, but not in multipotent progenitors. We do not detect effects on hematopoietic stem cells, or in peripheral blood. Notably, we do not detect severe myelodysplastic phenotypes or leukemia in this loss-of-function model. We conclude that Asxl1 is needed for normal hematopoiesis. The mild phenotypes observed may be because other Asxl genes have redundant function with Asxl1, or alternatively, MDS or oncogenic phenotypes may result from gain-of-function Asxl mutations caused by genomic amplification, gene fusion, or truncation of Asxl1.

Links

PubMed PMC2803690 Online version:10.1182/blood-2009-07-230698

Keywords

Animals; B-Lymphocytes/cytology; B-Lymphocytes/metabolism; Cell Count; Cell Lineage; Cells, Cultured; Flow Cytometry; Gene Targeting; Hematopoiesis/genetics; Hematopoietic Stem Cells/metabolism; Leukemia/genetics; Mice; Mice, Mutant Strains; Mutation/genetics; Myelodysplastic Syndromes/genetics; Myeloid Cells/pathology; Repressor Proteins/genetics; Splenomegaly/pathology; T-Lymphocytes/cytology; T-Lymphocytes/metabolism; Thymus Gland/cytology

public



Cancel